810 related articles for article (PubMed ID: 31439548)
1. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.
Mizutani Y; Iida T; Ohno E; Ishikawa T; Kinoshita F; Kuwatsuka Y; Imai M; Shimizu S; Tsuruta T; Enomoto A; Kawashima H; Fujishiro M
BMC Cancer; 2022 Feb; 22(1):205. PubMed ID: 35209871
[TBL] [Abstract][Full Text] [Related]
3. Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer.
Ichihara R; Shiraki Y; Mizutani Y; Iida T; Miyai Y; Esaki N; Kato A; Mii S; Ando R; Hayashi M; Takami H; Fujii T; Takahashi M; Enomoto A
Pathol Int; 2022 Mar; 72(3):161-175. PubMed ID: 35020975
[TBL] [Abstract][Full Text] [Related]
4. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.
Ando R; Shiraki Y; Miyai Y; Shimizu H; Furuhashi K; Minatoguchi S; Kato K; Kato A; Iida T; Mizutani Y; Ito K; Asai N; Mii S; Esaki N; Takahashi M; Enomoto A
J Pathol; 2024 Jan; 262(1):61-75. PubMed ID: 37796386
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics.
Iida T; Mizutani Y; Esaki N; Ponik SM; Burkel BM; Weng L; Kuwata K; Masamune A; Ishihara S; Haga H; Kataoka K; Mii S; Shiraki Y; Ishikawa T; Ohno E; Kawashima H; Hirooka Y; Fujishiro M; Takahashi M; Enomoto A
Oncogene; 2022 May; 41(19):2764-2777. PubMed ID: 35414659
[TBL] [Abstract][Full Text] [Related]
6. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
7. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis.
Takahashi M; Kobayashi H; Mizutani Y; Hara A; Iida T; Miyai Y; Asai N; Enomoto A
Front Cell Dev Biol; 2021; 9():749924. PubMed ID: 34676218
[TBL] [Abstract][Full Text] [Related]
8. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
9. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
[TBL] [Abstract][Full Text] [Related]
10. Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade.
Miyai Y; Sugiyama D; Hase T; Asai N; Taki T; Nishida K; Fukui T; Chen-Yoshikawa TF; Kobayashi H; Mii S; Shiraki Y; Hasegawa Y; Nishikawa H; Ando Y; Takahashi M; Enomoto A
Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35236758
[TBL] [Abstract][Full Text] [Related]
11. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction.
Hara A; Kobayashi H; Asai N; Saito S; Higuchi T; Kato K; Okumura T; Bando YK; Takefuji M; Mizutani Y; Miyai Y; Saito S; Maruyama S; Maeda K; Ouchi N; Nagasaka A; Miyata T; Mii S; Kioka N; Worthley DL; Murohara T; Takahashi M; Enomoto A
Circ Res; 2019 Aug; 125(4):414-430. PubMed ID: 31221024
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
13. Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model.
Miyazaki Y; Oda T; Inagaki Y; Kushige H; Saito Y; Mori N; Takayama Y; Kumagai Y; Mitsuyama T; Kida YS
Sci Rep; 2021 Feb; 11(1):4690. PubMed ID: 33633222
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.
Miyai Y; Esaki N; Takahashi M; Enomoto A
Cancer Sci; 2020 Apr; 111(4):1047-1057. PubMed ID: 32060987
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
[TBL] [Abstract][Full Text] [Related]
16. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
17. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.
Maeda K; Enomoto A; Hara A; Asai N; Kobayashi T; Horinouchi A; Maruyama S; Ishikawa Y; Nishiyama T; Kiyoi H; Kato T; Ando K; Weng L; Mii S; Asai M; Mizutani Y; Watanabe O; Hirooka Y; Goto H; Takahashi M
Sci Rep; 2016 Feb; 6():22288. PubMed ID: 26924503
[TBL] [Abstract][Full Text] [Related]
18. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
[TBL] [Abstract][Full Text] [Related]
19. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
20. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
